Global Oncology Molecular Diagnostics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	185 Pages	TechNavio	August, 2024	INF19287768

Best Price Guarantee
Price	from $2,500
Length	185 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19287768

Global Oncology Molecular Diagnostics Market 2024-2028

The oncology molecular diagnostics market is forecasted to grow by USD 3953.5 mn during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the oncology molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer worldwide, growing geriatric population, and increase in adoption of microarrays in genomics and proteomics.

Technavio's oncology molecular diagnostics market is segmented as below:

By Product
Reagents and kits
Instruments
By Type
Breast cancer
Colorectal cancer
Prostate cancer
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the integration of next-generation sequencing in oncology molecular diagnostics as one of the prime reasons driving the oncology molecular diagnostics market growth during the next few years. Also, adoption of various collaboration strategies and increasing focus on emerging countries for cancer diagnosis and treatment will lead to sizable demand in the market.

The report on the oncology molecular diagnostics market covers the following areas:

Oncology molecular diagnostics market sizing
Oncology molecular diagnostics market forecast
Oncology molecular diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology molecular diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., MDXHEALTH SA, Myriad Genetics Inc., QIAGEN NV, QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., TBG Diagnostics Ltd., Thermo Fisher Scientific Inc., and Veracyte Inc.. Also, the oncology molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Oncology Molecular Diagnostics Market 2018 - 2022; Historic Market Size - Data Table on Global Oncology Molecular Diagnostics Market 2018 - 2022 ($ million); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 Reagents and kits - Market size and forecast 2023-2028; Chart on Reagents and kits - Market size and forecast 2023-2028 ($ million); Data Table on Reagents and kits - Market size and forecast 2023-2028 ($ million); Chart on Reagents and kits - Year-over-year growth 2023-2028 (%); Data Table on Reagents and kits - Year-over-year growth 2023-2028 (%); 6.4 Instruments - Market size and forecast 2023-2028; Chart on Instruments - Market size and forecast 2023-2028 ($ million); Data Table on Instruments - Market size and forecast 2023-2028 ($ million); Chart on Instruments - Year-over-year growth 2023-2028 (%); Data Table on Instruments - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Breast cancer - Market size and forecast 2023-2028; Chart on Breast cancer - Market size and forecast 2023-2028 ($ million); Data Table on Breast cancer - Market size and forecast 2023-2028 ($ million); Chart on Breast cancer - Year-over-year growth 2023-2028 (%); Data Table on Breast cancer - Year-over-year growth 2023-2028 (%); 7.4 Colorectal cancer - Market size and forecast 2023-2028; Chart on Colorectal cancer - Market size and forecast 2023-2028 ($ million); Data Table on Colorectal cancer - Market size and forecast 2023-2028 ($ million); Chart on Colorectal cancer - Year-over-year growth 2023-2028 (%); Data Table on Colorectal cancer - Year-over-year growth 2023-2028 (%); 7.5 Prostate cancer - Market size and forecast 2023-2028; Chart on Prostate cancer - Market size and forecast 2023-2028 ($ million); Data Table on Prostate cancer - Market size and forecast 2023-2028 ($ million); Chart on Prostate cancer - Year-over-year growth 2023-2028 (%); Data Table on Prostate cancer - Year-over-year growth 2023-2028 (%); 7.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.11 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 Agilent Technologies Inc.; Agilent Technologies Inc. - Overview; Agilent Technologies Inc. - Business segments; Agilent Technologies Inc. - Key news; Agilent Technologies Inc. - Key offerings; Agilent Technologies Inc. - Segment focus; 12.5 bioMerieux SA; bioMerieux SA - Overview; bioMerieux SA - Product / Service; bioMerieux SA - Key news; bioMerieux SA - Key offerings; 12.6 Danaher Corp.; Danaher Corp. - Overview; Danaher Corp. - Business segments; Danaher Corp. - Key news; Danaher Corp. - Key offerings; Danaher Corp. - Segment focus; 12.7 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.8 Hologic Inc.; Hologic Inc. - Overview; Hologic Inc. - Business segments; Hologic Inc. - Key news; Hologic Inc. - Key offerings; Hologic Inc. - Segment focus; 12.9 HTG Molecular Diagnostics Inc.; HTG Molecular Diagnostics Inc. - Overview; HTG Molecular Diagnostics Inc. - Product / Service; HTG Molecular Diagnostics Inc. - Key offerings; 12.10 Illumina Inc.; Illumina Inc. - Overview; Illumina Inc. - Business segments; Illumina Inc. - Key news; Illumina Inc. - Key offerings; Illumina Inc. - Segment focus; 12.11 Myriad Genetics Inc.; Myriad Genetics Inc. - Overview; Myriad Genetics Inc. - Product / Service; Myriad Genetics Inc. - Key news; Myriad Genetics Inc. - Key offerings; 12.12 QIAGEN NV; QIAGEN NV - Overview; QIAGEN NV - Product / Service; QIAGEN NV - Key news; QIAGEN NV - Key offerings; 12.13 Siemens Healthineers AG; Siemens Healthineers AG - Overview; Siemens Healthineers AG - Business segments; Siemens Healthineers AG - Key news; Siemens Healthineers AG - Key offerings; Siemens Healthineers AG - Segment focus; 12.14 Sysmex Corp.; Sysmex Corp. - Overview; Sysmex Corp. - Business segments; Sysmex Corp. - Key news; Sysmex Corp. - Key offerings; Sysmex Corp. - Segment focus; 12.15 TBG Diagnostics Ltd.; TBG Diagnostics Ltd. - Overview; TBG Diagnostics Ltd. - Product / Service; TBG Diagnostics Ltd. - Key offerings; 12.16 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus; 12.17 Veracyte Inc.; Veracyte Inc. - Overview; Veracyte Inc. - Product / Service; Veracyte Inc. - Key news; Veracyte Inc. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Oncology Molecular Diagnostics Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product - Market share 2023-2028 (%); Exhibits33: Data Table on Product - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product; Exhibits35: Data Table on Comparison by Product; Exhibits36: Chart on Reagents and kits - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Reagents and kits - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Reagents and kits - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Reagents and kits - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Instruments - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Instruments - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Instruments - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Instruments - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Product ($ million); Exhibits45: Data Table on Market opportunity by Product ($ million); Exhibits46: Chart on Type - Market share 2023-2028 (%); Exhibits47: Data Table on Type - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Type; Exhibits49: Data Table on Comparison by Type; Exhibits50: Chart on Breast cancer - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Breast cancer - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Colorectal cancer - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Colorectal cancer - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Colorectal cancer - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Colorectal cancer - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Prostate cancer - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Prostate cancer - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Prostate cancer - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Prostate cancer - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Type ($ million); Exhibits67: Data Table on Market opportunity by Type ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ million); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: Abbott Laboratories - Overview; Exhibits118: Abbott Laboratories - Business segments; Exhibits119: Abbott Laboratories - Key news; Exhibits120: Abbott Laboratories - Key offerings; Exhibits121: Abbott Laboratories - Segment focus; Exhibits122: Agilent Technologies Inc. - Overview; Exhibits123: Agilent Technologies Inc. - Business segments; Exhibits124: Agilent Technologies Inc. - Key news; Exhibits125: Agilent Technologies Inc. - Key offerings; Exhibits126: Agilent Technologies Inc. - Segment focus; Exhibits127: bioMerieux SA - Overview; Exhibits128: bioMerieux SA - Product / Service; Exhibits129: bioMerieux SA - Key news; Exhibits130: bioMerieux SA - Key offerings; Exhibits131: Danaher Corp. - Overview; Exhibits132: Danaher Corp. - Business segments; Exhibits133: Danaher Corp. - Key news; Exhibits134: Danaher Corp. - Key offerings; Exhibits135: Danaher Corp. - Segment focus; Exhibits136: F. Hoffmann La Roche Ltd. - Overview; Exhibits137: F. Hoffmann La Roche Ltd. - Business segments; Exhibits138: F. Hoffmann La Roche Ltd. - Key news; Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits141: Hologic Inc. - Overview; Exhibits142: Hologic Inc. - Business segments; Exhibits143: Hologic Inc. - Key news; Exhibits144: Hologic Inc. - Key offerings; Exhibits145: Hologic Inc. - Segment focus; Exhibits146: HTG Molecular Diagnostics Inc. - Overview; Exhibits147: HTG Molecular Diagnostics Inc. - Product / Service; Exhibits148: HTG Molecular Diagnostics Inc. - Key offerings; Exhibits149: Illumina Inc. - Overview; Exhibits150: Illumina Inc. - Business segments; Exhibits151: Illumina Inc. - Key news; Exhibits152: Illumina Inc. - Key offerings; Exhibits153: Illumina Inc. - Segment focus; Exhibits154: Myriad Genetics Inc. - Overview; Exhibits155: Myriad Genetics Inc. - Product / Service; Exhibits156: Myriad Genetics Inc. - Key news; Exhibits157: Myriad Genetics Inc. - Key offerings; Exhibits158: QIAGEN NV - Overview; Exhibits159: QIAGEN NV - Product / Service; Exhibits160: QIAGEN NV - Key news; Exhibits161: QIAGEN NV - Key offerings; Exhibits162: Siemens Healthineers AG - Overview; Exhibits163: Siemens Healthineers AG - Business segments; Exhibits164: Siemens Healthineers AG - Key news; Exhibits165: Siemens Healthineers AG - Key offerings; Exhibits166: Siemens Healthineers AG - Segment focus; Exhibits167: Sysmex Corp. - Overview; Exhibits168: Sysmex Corp. - Business segments; Exhibits169: Sysmex Corp. - Key news; Exhibits170: Sysmex Corp. - Key offerings; Exhibits171: Sysmex Corp. - Segment focus; Exhibits172: TBG Diagnostics Ltd. - Overview; Exhibits173: TBG Diagnostics Ltd. - Product / Service; Exhibits174: TBG Diagnostics Ltd. - Key offerings; Exhibits175: Thermo Fisher Scientific Inc. - Overview; Exhibits176: Thermo Fisher Scientific Inc. - Business segments; Exhibits177: Thermo Fisher Scientific Inc. - Key news; Exhibits178: Thermo Fisher Scientific Inc. - Key offerings; Exhibits179: Thermo Fisher Scientific Inc. - Segment focus; Exhibits180: Veracyte Inc. - Overview; Exhibits181: Veracyte Inc. - Product / Service; Exhibits182: Veracyte Inc. - Key news; Exhibits183: Veracyte Inc. - Key offerings; Exhibits184: Inclusions checklist; Exhibits185: Exclusions checklist; Exhibits186: Currency conversion rates for US$; Exhibits187: Research methodology; Exhibits188: Information sources; Exhibits189: Data validation; Exhibits190: Validation techniques employed for market sizing; Exhibits191: Data synthesis; Exhibits192: 360 degree market analysis; Exhibits193: List of abbreviations